Researchers are excited about this new drug, a innovative dual treatment showing promising data in initial trials for body loss . It functions by impacting both pathways : GLP-1 and GIP, which , when https://katrinarxjc631251.ssnblog.com/39466008/a-new-possibility-for-weight-reduction